Dicerna Pharmaceuticals financial leverage is the degree to which the firm utilises its fixed-income securities. Companies with high leverage are usually considered to be at financial risk. Dicerna Pharmaceuticals financial risk is the risk to Dicerna Pharmaceuticals stockholders that is caused by an increase in debt. In other words with a high degree of financial leverage come high interest payments which usually reduces Earnings Per Share (EPS). Additionally see analysis of Dicerna Pharmaceuticals Fundamentals Over Time.
Dicerna Pharmaceuticals Financial Leverage Rating
Total Macroaxis Rating
Average S&P Rating
Dicerna Pharmaceuticals Debt to Cash Allocation
The company currently holds 2.68 M in liabilities with Debt to Equity (D/E) ratio of 1.6 which is about average as compared to similar companies. Dicerna Pharmaceuticals has Current Ratio of 3.58 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Dicerna Pharmaceuticals Receivables Over Time
Dicerna Pharmaceuticals Historical Liabilities
Check upcoming earnings announcements updated hourly across public exchanges
|All Next||Launch Module|
Additionally see analysis of Dicerna Pharmaceuticals Fundamentals Over Time. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.